Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 18,992 | 69,798 | 76,321 | 17,291 | 46,498 |
| Cost of Goods | -27 | -789 | 1,295 | 2,266 | 529 |
| Gross Profit | 19,019 | 70,587 | 75,026 | 15,025 | 45,969 |
| Operating Expenses | 69,202 | 80,253 | 78,435 | 84,702 | 86,862 |
| Operating Income | -50,210 | -10,455 | -3,114 | -69,411 | -40,364 |
| Interest Expense | 10,291 | 7,357 | 11,356 | 8,801 | 9,217 |
| Other Income | 1,645 | 5,466 | -36,849 | 12,891 | 31,750 |
| Pre-tax Income | -58,856 | -12,346 | -51,319 | -65,321 | -17,831 |
| Income Tax | 518 | 3,055 | -711 | -947 | -1,170 |
| Net Income Continuous | -59,374 | -25,485 | -50,608 | -64,374 | -16,661 |
| Net Income | $-59,374 | $-25,485 | $-50,608 | $-64,374 | $-16,661 |
| EPS Basic Total Ops | -0.73 | -0.30 | -0.65 | -0.84 | -0.22 |
| EPS Basic Continuous Ops | -0.73 | -0.31 | -0.65 | -0.84 | -0.22 |
| EPS Diluted Total Ops | -0.73 | -0.30 | -0.65 | -0.84 | -0.22 |
| EPS Diluted Continuous Ops | -0.73 | -0.31 | -0.65 | -0.84 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.74 | -0.30 | -0.65 | N/A | N/A |
| EBITDA(a) | $-49,487 | $-9,819 | $-2,542 | $-68,825 | $-39,770 |